DISEASE INDICATIONS: Spinal Muscular Atrophy
MANUFACTURER: Biogen Idec Ltd
USAGE: Intrathecal Injection
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Spinraza, also known by its generic name Nusinersen, is a groundbreaking medication that has transformed the landscape of treatment for Spinal Muscular Atrophy (SMA), a rare genetic disorder characterized by the progressive degeneration of motor neurons in the spinal cord.
